Losartan potassium and Renal impairment - a phase IV clinical study of FDA data
Renal impairment is found among people who take Losartan potassium, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Losartan potassium and have Renal impairment. It is created by eHealthMe based on reports of 40,425 people who have side effects when taking Losartan potassium from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
40,425 people reported to have side effects when taking Losartan potassium.
Among them, 436 people (1.08%) have Renal impairment.
What is Losartan potassium?
Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 41,801 Losartan potassium users for its effectiveness, alternative drugs and more.
What is Renal impairment?
Renal impairment (severely reduced kidney function) is found to be associated with 2,647 drugs and 2,332 conditions by eHealthMe.
Number of Losartan potassium and Renal impairment reports submitted per year:
Time on Losartan potassium when people have Renal impairment *:
Gender of people who have Renal impairment when taking Losartan potassium*:
Age of people who have Renal impairment when taking Losartan potassium *:
Common drugs people take besides Losartan potassium *:
Common side effects people have besides Renal impairment *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Losartan potassium and have Renal impairment?Check whether Renal impairment is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lin HF, Lin CL, Liao KF, "No association between losartan use and acute pancreatitis in hypertensive patients", Eur J Hosp Pharm, 2017 Mar .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
How severe was Renal impairment and when was it recovered:
Expand to all the drugs that have ingredients of losartan potassium:
Alternative drugs to, pros and cons of Losartan potassium:
- Losartan potassium (41,801 reports)
Common Losartan potassium side effects:
Browse all side effects of Losartan potassium:a b c d e f g h i j k l m n o p q r s t u v w x y z
Renal impairment treatments and more:
- Renal impairment (85,016 reports)
COVID vaccines that are related to Renal impairment:
- Renal impairment in Moderna COVID Vaccine
- Renal impairment in Pfizer BioNTech Covid Vaccine
- Renal impairment in Johnson and Johnson Covid Vaccine
Common drugs associated with Renal impairment:
All the drugs that are associated with Renal impairment:
- Renal impairment (2,647 drugs)
Common conditions associated with Renal impairment:
All the conditions that are associated with Renal impairment:
- Renal impairment (2,332 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on losartan potassium (the active ingredients of Losartan potassium) and Losartan potassium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Etoposide and Mental Status Changes - 2 seconds ago
- Cetirizine Hydrochloride Allergy vs. Sudafed 12 Hour - 4 seconds ago
- Zoladex and Bladder Cancer - 6 seconds ago
- Duragesic-100 and Incontinence - 14 seconds ago
- Lexapro and Adrenal Adenoma - 14 seconds ago
- Humira and Ultrasound Liver Abnormal - 14 seconds ago
- Claritin and Escherichia Sepsis - 21 seconds ago
- Nexium and Bromday drug interaction - 22 seconds ago
- Benztropine Mesylate and Blunted Affect - 23 seconds ago
- Alupent and Isosorbide Mononitrate drug interaction - 25 seconds ago